Articles:

Novel CD44 messenger RNA isoforms in human thyroid and breast tissues feature unusual sequence rearrangements

G Ermak, T Jennings, A Boguniewicz, and J Figge
Clin Cancer Res 1996 2: 1251 [Abstract] [PDF]  

Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues

IY Kim, HJ Ahn, DJ Zelner, JW Shaw, S Lang, M Kato, MG Oefelein, K Miyazono, JA Nemeth, JM Kozlowski, and C Lee
Clin Cancer Res 1996 2: 1255 [Abstract] [PDF]  

Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy

H Rabinowich, M Banks, TE Reichert, TF Logan, JM Kirkwood, and TL Whiteside
Clin Cancer Res 1996 2: 1263 [Abstract] [PDF]  

Pharmacodynamics of doxorubicin in human bladder tumors

Y Gan, MG Wientjes, RA Badalament, and JL Au
Clin Cancer Res 1996 2: 1275 [Abstract] [PDF]  

Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix

AP Kudelka, R Winn, CL Edwards, G Downey, H Greenberg, SR Dakhil, RS Freedman, E Loyer, J Rusinkiewicz, P Gacrama, R Fueger, and JJ Kavanagh
Clin Cancer Res 1996 2: 1285 [Abstract] [PDF]  

Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody

N Deb, M Goris, K Trisler, S Fowler, J Saal, S Ning, M Becker, C Marquez, and S Knox
Clin Cancer Res 1996 2: 1289 [Abstract] [PDF]  

Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study

CJ McGinn, KA Kunugi, KD Tutsch, C Feierabend, D Alberti, MJ Lindstrom, G Wilding, RZ Arzoomanian, and TJ Kinsella
Clin Cancer Res 1996 2: 1299 [Abstract] [PDF]  

Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells

A Frankel and GB Mills
Clin Cancer Res 1996 2: 1307 [Abstract] [PDF]  

Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: analysis in a preclinical survival model

D Glaves, MK Murray, and D Raghavan
Clin Cancer Res 1996 2: 1315 [Abstract] [PDF]  

Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP)

RG Manzano, KA Wright, and PR Twentyman
Clin Cancer Res 1996 2: 1321 [Abstract] [PDF]  

Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model

JA van Laar, CL van der Wilt, YM Rustum, P Noordhuis, K Smid, HM Pinedo, and GJ Peters
Clin Cancer Res 1996 2: 1327 [Abstract] [PDF]  

Anticarcinoma activity of a novel drug, 3-ethyl-3'-methyl-thiatelluracarbocyanine iodide (Te), a tellurium-containing cyanine targeted at mitochondria

X Sun, JR Wong, K Song, and LB Chen
Clin Cancer Res 1996 2: 1335 [Abstract] [PDF]  

Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera

EG Trehu, JW Mier, JS Dubois, D Sorce, MS Klempner, M Epstein, CA Dinarello, L Shapiro, K Kappler, L Ronayne, and MB Atkins
Clin Cancer Res 1996 2: 1341 [Abstract] [PDF]  

Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors

JA Allay, ON Koc, BM Davis, and SL Gerson
Clin Cancer Res 1996 2: 1353 [Abstract] [PDF]  

Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma

K Kramer, W Gerald, L LeSauteur, H Uri Saragovi, and NK Cheung
Clin Cancer Res 1996 2: 1361 [Abstract] [PDF]  

TIMP1 and adverse prognosis in non-small cell lung cancer

KM Fong, Y Kida, PV Zimmerman, and PJ Smith
Clin Cancer Res 1996 2: 1369 [Abstract] [PDF]  

Immunohistochemical detection of K-sam protein in stomach cancer

Y Hattori, H Itoh, S Uchino, K Hosokawa, A Ochiai, Y Ino, H Ishii, H Sakamoto, N Yamaguchi, K Yanagihara, S Hirohashi, T Sugimura, and M Terada
Clin Cancer Res 1996 2: 1373 [Abstract] [PDF]  

Interleukin 10 production by human melanoma

T Sato, P McCue, K Masuoka, S Salwen, EC Lattime, MJ Mastrangelo, and D Berd
Clin Cancer Res 1996 2: 1383 [Abstract] [PDF]  

Mutant p53 expression: a marker of diminished survival in well-differentiated soft tissue sarcoma

TJ Hieken and TK Das Gupta
Clin Cancer Res 1996 2: 1391 [Abstract] [PDF]  

Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases

NM Han, SA Curley, and GE Gallick
Clin Cancer Res 1996 2: 1397 [Abstract] [PDF]  

Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden

R Mouawad, A Benhammouda, O Rixe, EC Antoine, C Borel, M Weil, D Khayat, and C Soubrane
Clin Cancer Res 1996 2: 1405 [Abstract] [PDF]  

Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer

Y Ohta, Y Endo, M Tanaka, J Shimizu, M Oda, Y Hayashi, Y Watanabe, and T Sasaki
Clin Cancer Res 1996 2: 1411 [Abstract] [PDF]  

Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells

C Lu, C Sheehan, JW Rak, CA Chambers, N Hozumi, and RS Kerbel
Clin Cancer Res 1996 2: 1417 [Abstract] [PDF]  

Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression

B Seliger, A Hohne, A Knuth, H Bernhard, B Ehring, R Tampe, and C Huber
Clin Cancer Res 1996 2: 1427 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.